PubMed · 2010 · 30 citations · 12 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyMolecular PharmacologyBreast Cancer PharmacotherapyHormonal Cancer TherapyHormonal TherapyOncology PharmacologyBreast Cancer Endocrine TherapyBreast Cancer Hormonal TherapyBreast Cancer Hormone TherapyEstrogen PharmacologyEstrogen Receptor SignalingHormone Receptor - Positive Breast CancerHormone Receptor ModulationHormone Receptor-positive Breast Cancer Therapy
BACKGROUND: Tamoxifen, a selective estrogen receptor modulator, and fulvestrant, a selective estrogen receptor down-regulator (SERD), are now available for estrogen receptor-positive breast cancer patients. However, these patients acquire drug-resistance during the treatments. We identified a new orally active nonsteroidal SERD, CH4986399, which is structurally unrelated to fulvestrant and tamoxifen. MATERIALS AND METHODS: We examined the oral antitumor activity and down-regulation of ER by CH4986399 in human breast cancer Br-10 and ZR-75-1 xenografts. RESULTS: In the Br-10 xenografts, CH4986399 (100 mg/kg p.o.) as well as fulvestrant (3 mg/body s.c.) strongly reduced tumor weight. In the ZR-75-1 xenografts, CH4986399 (100 mg/kg p.o.) strongly reduced tumor weight and ER content without agonistic activity. In contrast, tamoxifen (100 mg/kg p.o.) showed only moderate antitumor activity and no ER down-regulation. CONCLUSION: With a chemical structure different from both fulvestrant and tamoxifen, CH4986399, may help overcome drug resistance from the endocrine treatment sequence for breast cancer patients.
12
A potent specific pure antiestrogen with clinical potential.
A. E. Wakeling, Michael Dukes, Jean Bowler · PubMed · 1991 · 1.1K citations
Anthony Howell, J.F.R. Robertson, J. Albano et al. · Journal of Clinical Oncology · 2002 · 669 citations
Medicine, Oncology, Pharmacology +14
C. Kent Osborne, John Pippen, Stephen E. Jones et al. · Journal of Clinical Oncology · 2002 · 643 citations
Medicine, Oncology, Pharmacology +14
Anthony Howell, J.F.R. Robertson, P. Abram et al. · Journal of Clinical Oncology · 2004 · 425 citations · Full text
Medicine, Oncology, Pharmacotherapy +16
Thomas Frogne, Rikke Vicki Benjaminsen, Katrine Sonne‐Hansen et al. · Breast Cancer Research and Treatment · 2008 · 155 citations · Full text